ObsEva SA, en liquidation is a Switzerland-based company which provides services in the fields of research, development, manufacture, registration, promotion and marketing of biotechnical and pharmaceutical products.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	41.01L 35.52L 33.11L 30.45L 57.49L 39Cr 58.13L 3.89Cr 1.53Cr 20Cr 1.54Cr 1.51Cr 65Cr	P/E 2021	-2.57x	P/E 2022	-0.45x
Enterprise Value	-12.96L -11.22L -10.46L -10L -18.16L -12Cr -18.37L -1.23Cr -48.25L -6.16Cr -48.67L -47.59L -20Cr	EV / Sales 2021	-	EV / Sales 2022	0.65x
Free-Float	70.16%	Yield 2021 *	-	Yield 2022	-

20/23/20	ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq	MT
20/23/20	ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9%	MT
12/23/12	Insider Buy: Obseva	MT
06/23/06	ObsEva SA announced that it has received CHF 0.344 million in funding	CI
01/23/01	ObsEva SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
31/23/31	ObsEva SA Auditor Raises 'Going Concern' Doubt	CI
22/23/22	ObsEva SA(OTCPK:OBSV.F) dropped from NASDAQ Composite Index	CI
15/23/15	ObsEva to Delist from Nasdaq, Deregister from US SEC	MT
13/23/13	ObsEva Names New CEO From May, Appoints Interim Chairman	MT
13/23/13	ObsEva Names New Interim Chairman, CEO as Reorganization Continues	MT
13/23/13	ObsEva SA Announces CEO Changes, Effective on or About May 1, 2023	CI
13/23/13	ObsEva SA Announces Executive Changes	CI
03/23/03	Top Premarket Gainers	MT

30/22/30	HC Wainwright Downgrades ObsEva to Neutral from Buy	MT
01/22/01	Canaccord Genuity Downgrades ObsEva to Hold From Buy, Adjusts Price Target to $1 From $12	MT
29/22/29	Cantor Fitzgerald Cuts ObsEva to Neutral From Overweight, Price Target to $1 From $6	MT
03/22/03	Cantor Fitzgerald Starts ObsEva at Overweight With $6 Price Target	MT
26/22/26	Canaccord Genuity Starts ObsEva at Buy With $12 Price Target	MT

20/23/20	ObsEva Announces Change of Central Securities Depositary	GL
20/23/20	ObsEva Announces Change of Central Securities Depositary	GL
01/23/01	ObsEva Files Year End 2022 Financial Statements	GL
23/23/23	OBSEVA SA : Other Events (form 8-K)	AQ
15/23/15	ObsEva : Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange - Form 8-K	PU

20/23/20	Obseva-Aktien erhalten im Zuge von Nasdaq-Dekotierung neue ISIN-Nummer
06/23/06	Bourse Zurich: le SMI maintient ses gains à l'approche de la mi-journée
06/23/06	Bourse Zurich: ouverture en hausse avant le long week-end pascal
01/23/01	Obseva bleibt 2022 tief in den roten Zahlen
01/23/01	Obseva reste profondément en rouge en 2022, doutes sur la suite

ObsEva SA Share Price Swiss Exchange

Stocks

OBSN

CH1260041939

Biotechnology & Medical Research

Valuation: ObsEva SA

Latest news : ObsEva SA

Analysts' recommendations: ObsEva SA

Press Releases: ObsEva SA

News in other languages: ObsEva SA

Quotes and Performance

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OBSEVA SA	-76.92%	-86.36%	-	-	117
WUXI APPTEC CO., LTD.	+4.35%	+16.60%	+58.11%	+95.21%	6.49TCr
ARGENX SE	+1.82%	+2.09%	+30.83%	+72.40%	5.41TCr
BIONTECH SE	+0.91%	-0.83%	-17.01%	-13.43%	2.32TCr
INSMED INCORPORATED	+0.27%	-3.98%	-11.28%	+350.30%	2.15TCr
WUXI BIOLOGICS (CAYMAN) INC.	+1.87%	+9.47%	+30.87%	-5.63%	2.13TCr
GENMAB A/S	+0.62%	+3.17%	+38.16%	-25.13%	1.79TCr
PHARMAESSENTIA CORPORATION	+9.88%	+23.61%	+222.87%	+385.49%	1.7TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.29%	+5.61%	+21.01%	+636.23%	1.5TCr
EXELIXIS, INC.	+1.25%	+2.48%	+51.36%	+179.72%	1.43TCr
Average	-5.46%	+5.03%	+47.21%	+186.13%	2.77TCr
Weighted average by Cap.	+2.60%	+5.90%	+44.11%	+142.11%

	2021	2022
Net sales	-	1.96Cr 1.7Cr 1.59Cr 1.46Cr 2.75Cr 186.72Cr 2.78Cr 19Cr 7.31Cr 93Cr 7.38Cr 7.21Cr 309.42Cr
Net income	-5.84Cr -5.06Cr -4.71Cr -4.33Cr -8.18Cr -555.09Cr -8.27Cr -55Cr -22Cr -277.74Cr -22Cr -21Cr -919.85Cr	-2.99Cr -2.59Cr -2.41Cr -2.22Cr -4.19Cr -284.11Cr -4.24Cr -28Cr -11Cr -142.15Cr -11Cr -11Cr -470.8Cr
Net Debt	-2.81Cr -2.43Cr -2.27Cr -2.08Cr -3.94Cr -266.96Cr -3.98Cr -27Cr -10Cr -133.57Cr -11Cr -10Cr -442.38Cr	-53.97L -46.74L -43.57L -40.08L -75.66L -51Cr -76.5L -5.12Cr -2.01Cr -26Cr -2.03Cr -1.98Cr -85Cr